Reviewed clinical summary · Source-linked · Educational use only

Is a School-Based App Intervention Cost-Effective for Reducing Childhood Obesity in China?

Clinical Bottom Line

A health-economic evaluation finds a school-based app obesity-prevention programme cost-effective in Chinese primary schools. PICO summary and expert commentary.

Summary: In a health-economic evaluation of the DECIDE-Children trial, a one-year multi-component, app-assisted obesity-prevention programme in Chinese primary schools was cost-effective, gaining a QALY for about USD 4,644 and reducing BMI, body fat, and waist circumference versus usual health education.

PICO Summary

ElementDetail
PopulationChildren aged 8–10 across 24 primary schools in three socioeconomically distinct regions of China (cluster RCT).
InterventionDECIDE-Children: 1-year school, family, and digital programme with a mobile app for education, behaviour tracking, and weight-management feedback.
ComparisonUsual care (standard school health education).
OutcomeTotal cost USD 13,769.74 (USD 19.53/student). ICERs: USD 42.46 per 1-unit BMI reduction, USD 11.49 per 0.1 BMI Z-score, USD 18.60 per 1% body fat, USD 11.98 per 1 cm waist. ICUR USD 4,644.42 per QALY; cost-benefit ratio 0.84. Projected national rollout: 419,040 QALYs and USD 1.86 billion net benefit. Sensitivity analyses robust.

Expert Commentary

Childhood obesity prevention lives or dies on whether anyone will actually fund it at scale, so a proper economic evaluation rather than another efficacy paper is genuinely welcome, and this one is methodologically thorough, with ICERs across several anthropometric outcomes, a QALY-based cost-utility figure, and sensitivity analyses. At under twenty dollars per student and roughly USD 4,644 per QALY, the programme looks comfortably cost-effective by most thresholds, and that is the headline I trust most. My caution is about what economic modelling inevitably involves: the long-term QALYs and the USD 1.86 billion national projection rest on an obesity-progression model extrapolating childhood anthropometry decades forward, and such models are only as good as their assumptions, however reassuring the sensitivity analyses. A cost-benefit ratio of 0.84 also means monetised benefits did not quite exceed costs on that particular metric, which the QALY framing softens. Can I use this with my patients? Not directly as a clinician, but it is solid ammunition for the public-health and policy case for integrated school-family-digital prevention, especially in comparable middle-income settings. I would want real-world budget-impact data from an actual rollout before treating the billion-dollar figure as anything more than a well-constructed projection.

References

Yan S, Zhou S, Guo X, et al. Economic evaluation of a multi-component obesity prevention intervention in Chinese primary schools. BMC Med. 2025;23(1):653. doi:10.1186/s12916-025-04451-x

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.